User profiles for Kai C. Wollert

Kai C. Wollert

Professor, Hannover Medical School
Verified email at mh-hannover.de
Cited by 27360

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

KC Wollert, GP Meyer, J Lotz, SR Lichtenberg… - The Lancet, 2004 - thelancet.com
Kai C Wollert and Gerd P Meyer contributed equally to this work. We thank Alix Menke
and Dieter Fischer for analysing the coronary angiograms; our colleagues and nurses at the …

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to …

GP Meyer, KC Wollert, J Lotz, J Steffens, P Lippolt… - Circulation, 2006 - Am Heart Assoc
Background— Intracoronary transfer of autologous bone marrow cells (BMCs) may enhance
recovery of left ventricular (LV) function in patients after acute myocardial infarction (AMI). …

Monitoring of bone marrow cell homing into the infarcted human myocardium

M Hofmann, KC Wollert, GP Meyer, A Menke… - Circulation, 2005 - Am Heart Assoc
Background— Intracoronary transfer of autologous bone marrow cells (BMCs) promotes
recovery of left ventricular systolic function in patients with acute myocardial infarction. Although …

The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

…, HW Niessen, H Drexler, KC Wollert - Circulation …, 2006 - Am Heart Assoc
Data from the Women’s Health Study show that serum levels of growth-differentiation factor-15
(GDF-15), a distant member of the transforming growth factor-β superfamily, are an …

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome

…, K Bethmann, T Kempf, KC Wollert… - Journal of molecular and …, 2011 - Elsevier
Circulating microRNAs may have diagnostic potential in acute coronary syndrome (ACS).
Previous studies, however, were based on low patient numbers and could not assess the …

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

…, C Laudanna, N Hogg, D Vestweber, KC Wollert - Nature medicine, 2011 - nature.com
Inflammatory cell recruitment after myocardial infarction needs to be tightly controlled to
permit infarct healing while avoiding fatal complications such as cardiac rupture. Growth …

[HTML][HTML] Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy: ASSEMBLY OF SARCOMERIC UNITS IN SERIES VIA gp130/LEUKEMIA …

KC Wollert, T Taga, M Saito, M Narazaki… - Journal of Biological …, 1996 - ASBMB
Cardiotrophin-1 (CT-1) was recently isolated by expression cloning based on its ability to
induce an increase in cell size in neonatal rat ventricular cardiomyocytes. Sequence similarity …

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study

TJ Wang, KC Wollert, MG Larson, E Coglianese… - Circulation, 2012 - Am Heart Assoc
Background— Biomarkers for predicting cardiovascular events in community-based populations
have not consistently added information to standard risk factors. A limitation of many …

Clinical applications of stem cells for the heart

KC Wollert, H Drexler - Circulation research, 2005 - Am Heart Assoc
Repair of the heart is an old dream of physicians caring for patients with cardiac disease.
Experimental studies suggest that cardiac transfer of stem and progenitor cells can have a …

Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure

…, P Rozentryt, H Drexler, SD Anker, KC Wollert - Journal of the American …, 2007 - jacc.org
Objectives : We explored the prognostic utility of growth differentiation factor (GDF)-15 in
patients with chronic heart failure (CHF). Background : Growth differentiation factor-15 is a stress…